Recent Finacing
Recent Raise
Drug Farm uses an IDInVivo genetics and AI platform to assess gene targets in animals and develops ALPK1-targeting immunomodulators (DF-006, DF-003) for HBV, cardio-renal disease, and ROSAH.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Drug Farm.
